These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 19188748

  • 21. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ, Haqq CM, Simko J, Nonaka DF, Chan JM, Weinberg V, Small EJ, Goldfine ID.
    Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
    Thomas C, Wiesner C, Melchior SW, Schmidt F, Gillitzer R, Thüroff JW, Pfitzenmaier J.
    BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
    [Abstract] [Full Text] [Related]

  • 25. [Relationship of neuroendocrine differentiation to biological behavior of prostate cancer].
    Wu XL, Huang KT, Chen W, Chen L, Dong L, Yu ZX.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 24; 89(7):472-5. PubMed ID: 19567097
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Immunohistochemical study of chromogranin A in Stage D2 prostate cancer.
    Kokubo H, Yamada Y, Nishio Y, Fukatsu H, Honda N, Nakagawa A, Saga S, Tsuzuki T, Hara K.
    Urology; 2005 Jul 24; 66(1):135-40. PubMed ID: 15992907
    [Abstract] [Full Text] [Related]

  • 28. Increased Akt and phosphorylated Akt expression are associated with malignant biological features of prostate cancer in Japanese men.
    Shimizu Y, Segawa T, Inoue T, Shiraishi T, Yoshida T, Toda Y, Yamada T, Kinukawa N, Terada N, Kobayashi T, Kinoshita H, Kamoto T, Nakamura E, Ogawa O.
    BJU Int; 2007 Sep 24; 100(3):685-90. PubMed ID: 17542985
    [Abstract] [Full Text] [Related]

  • 29. Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.
    Bass R, Perry B, Langenstroer P, Thrasher JB, Dennis KL, Tawfik O, Holzbeierlein J.
    J Urol; 2009 Feb 24; 181(2):615-9; discussion 619-20. PubMed ID: 19091346
    [Abstract] [Full Text] [Related]

  • 30. Is neuroendocrine cell differentiation detected using chromogranin A from patients with bone metastatic prostate cancer a prognostic factor for outcome?
    Yamada Y, Nakamura K, Aoki S, Taki T, Matsubara H, Sai S, Naruse K, Tobiume M, Katsuda R, Zennami K, Honda N, Nakagawa A, Ikeda H.
    Oncol Rep; 2006 May 24; 15(5):1309-13. PubMed ID: 16596203
    [Abstract] [Full Text] [Related]

  • 31. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.
    Clin Cancer Res; 2009 May 15; 15(10):3557-67. PubMed ID: 19447876
    [Abstract] [Full Text] [Related]

  • 32. Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review.
    Qiu YQ, Leuschner I, Braun PM.
    Asian J Androl; 2008 Nov 15; 10(6):855-63. PubMed ID: 18958349
    [Abstract] [Full Text] [Related]

  • 33. [Prognostic significance of cell proliferation, microvascular density and androgen receptor level in prostatic adenocarcinoma].
    Lefterov SI, Gorelov SI, Krivolapov IuA.
    Vopr Onkol; 2009 Nov 15; 55(6):740-5. PubMed ID: 20210018
    [Abstract] [Full Text] [Related]

  • 34. Prostate-specific antigen and prostate-specific acid phosphatase in neuroendocrine cells of prostate cancer.
    Cohen RJ, Glezerson G, Haffejee Z.
    Arch Pathol Lab Med; 1992 Jan 15; 116(1):65-6. PubMed ID: 1370878
    [Abstract] [Full Text] [Related]

  • 35. Reduced expression of alpha-tocopherol-associated protein is associated with tumor cell proliferation and the increased risk of prostate cancer recurrence.
    Wen XQ, Li XJ, Su ZL, Liu Y, Zhou XF, Cai YB, Huang WT, Gao X.
    Asian J Androl; 2007 Mar 15; 9(2):206-12. PubMed ID: 17334589
    [Abstract] [Full Text] [Related]

  • 36. The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.
    Mosca A, Berruti A, Russo L, Torta M, Dogliotti L.
    J Endocrinol Invest; 2005 Mar 15; 28(11 Suppl International):141-5. PubMed ID: 16625864
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
    Bonkhoff H.
    Prostate Suppl; 1998 Mar 15; 8():18-22. PubMed ID: 9690659
    [Abstract] [Full Text] [Related]

  • 39. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
    Fixemer T, Remberger K, Bonkhoff H.
    Prostate; 2002 Oct 01; 53(2):118-23. PubMed ID: 12242726
    [Abstract] [Full Text] [Related]

  • 40. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line.
    Ischia R, Culig Z, Eder U, Bartsch G, Winkler H, Fischer-Colbrie R, Klocker H.
    Prostate Suppl; 1998 Oct 01; 8():80-7. PubMed ID: 9690667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.